117 related articles for article (PubMed ID: 1322481)
1. 2-Bromomelatonin: synthesis and characterization of a potent melatonin agonist.
Duranti E; Stankov B; Spadoni G; Duranti A; Lucini V; Capsoni S; Biella G; Fraschini F
Life Sci; 1992; 51(7):479-85. PubMed ID: 1322481
[TBL] [Abstract][Full Text] [Related]
2. Melatonin signal transduction and mechanism of action in the central nervous system: using the rabbit cortex as a model.
Stankov B; Biella G; Panara C; Lucini V; Capsoni S; Fauteck J; Cozzi B; Fraschini F
Endocrinology; 1992 Apr; 130(4):2152-9. PubMed ID: 1312448
[TBL] [Abstract][Full Text] [Related]
3. Iodinated melatonin: preparation and characterization of the molecular structure by mass and 1H NMR spectroscopy.
Vakkuri O; Lämsä E; Rahkamaa E; Ruotsalainen H; Leppäluoto J
Anal Biochem; 1984 Nov; 142(2):284-9. PubMed ID: 6549370
[TBL] [Abstract][Full Text] [Related]
4. 2-Substituted 5-methoxy-N-acyltryptamines: synthesis, binding affinity for the melatonin receptor, and evaluation of the biological activity.
Spadoni G; Stankov B; Duranti A; Biella G; Lucini V; Salvatori A; Fraschini F
J Med Chem; 1993 Dec; 36(25):4069-74. PubMed ID: 8258829
[TBL] [Abstract][Full Text] [Related]
5. Characterization and mapping of melatonin receptors in the brain of three mammalian species: rabbit, horse and sheep. A comparative in vitro binding study.
Stankov B; Cozzi B; Lucini V; Fumagalli P; Scaglione F; Fraschini F
Neuroendocrinology; 1991 Mar; 53(3):214-21. PubMed ID: 1645852
[TBL] [Abstract][Full Text] [Related]
6. 2-[125I]iodomelatonin binding sites in hamster and chick exhibit differential sensitivity to prazosin.
Pickering DS; Niles LP
J Pharm Pharmacol; 1989 May; 41(5):356-7. PubMed ID: 2569529
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological characterization of melatonin binding sites in Syrian hamster hypothalamus.
Pickering DS; Niles LP
Eur J Pharmacol; 1990 Jan; 175(1):71-7. PubMed ID: 2157597
[TBL] [Abstract][Full Text] [Related]
8. Melatonin: structural characterization of its non-enzymatic mono-oxygenate metabolite.
Agozzino P; Avellone G; Bongiorno D; Ceraulo L; Filizzola F; Natoli MC; Livrea MA; Tesoriere L
J Pineal Res; 2003 Nov; 35(4):269-75. PubMed ID: 14521633
[TBL] [Abstract][Full Text] [Related]
9. 2-[125I]iodomelatonin binding sites in hamster brain membranes: pharmacological characteristics and regional distribution.
Duncan MJ; Takahashi JS; Dubocovich ML
Endocrinology; 1988 May; 122(5):1825-33. PubMed ID: 2834175
[TBL] [Abstract][Full Text] [Related]
10. Ligand efficacy and potency at recombinant human MT2 melatonin receptors: evidence for agonist activity of some mt1-antagonists.
Nonno R; Pannacci M; Lucini V; Angeloni D; Fraschini F; Stankov BM
Br J Pharmacol; 1999 Jul; 127(5):1288-94. PubMed ID: 10455277
[TBL] [Abstract][Full Text] [Related]
11. Affinity labeling of melatonin binding sites in the hamster brain.
Anis Y; Zisapel N
Biochem Biophys Res Commun; 1991 Aug; 178(3):1147-52. PubMed ID: 1651713
[TBL] [Abstract][Full Text] [Related]
12. GR196429: a nonindolic agonist at high-affinity melatonin receptors.
Beresford IJ; Browning C; Starkey SJ; Brown J; Foord SM; Coughlan J; North PC; Dubocovich ML; Hagan RM
J Pharmacol Exp Ther; 1998 Jun; 285(3):1239-45. PubMed ID: 9618428
[TBL] [Abstract][Full Text] [Related]
13. 7-Substituted-melatonin and 7-substituted-1-methylmelatonin analogues: effect of substituents on potency and binding affinity.
Faust R; Garratt PJ; Trujillo Pérez MA; Piccio VJ; Madsen C; Stenstrøm A; Frølund B; Davidson K; Teh MT; Sugden D
Bioorg Med Chem; 2007 Jul; 15(13):4543-51. PubMed ID: 17459711
[TBL] [Abstract][Full Text] [Related]
14. 2-[125I]iodomelatonin labels sites with identical pharmacological characteristics in chicken brain and chicken retina.
Dubocovich ML; Shankar G; Mickel M
Eur J Pharmacol; 1989 Mar; 162(2):289-99. PubMed ID: 2542059
[TBL] [Abstract][Full Text] [Related]
15. Characterization and regulation of the human ML1A melatonin receptor stably expressed in Chinese hamster ovary cells.
Witt-Enderby PA; Dubocovich ML
Mol Pharmacol; 1996 Jul; 50(1):166-74. PubMed ID: 8700109
[TBL] [Abstract][Full Text] [Related]
16. Characterization of 2-[125I]iodomelatonin-binding sites in quail testes at mid-light and mid-dark.
Wang ZP; Cheng KM; Brown GM; Pang CS; Pang SF
Neurosci Lett; 1992 Nov; 146(2):195-8. PubMed ID: 1337195
[TBL] [Abstract][Full Text] [Related]
17. Novel bromomelatonin derivatives suppress osteoclastic activity and increase osteoblastic activity: implications for the treatment of bone diseases.
Suzuki N; Somei M; Kitamura K; Reiter RJ; Hattori A
J Pineal Res; 2008 Apr; 44(3):326-34. PubMed ID: 18339128
[TBL] [Abstract][Full Text] [Related]
18. Reassessing the melatonin pharmacophore--enantiomeric resolution, pharmacological activity, structure analysis, and molecular modeling of a constrained chiral melatonin analogue.
Rivara S; Diamantini G; Di Giacomo B; Lamba D; Gatti G; Lucini V; Pannacci M; Mor M; Spadoni G; Tarzia G
Bioorg Med Chem; 2006 May; 14(10):3383-91. PubMed ID: 16431121
[TBL] [Abstract][Full Text] [Related]
19. N-bromoacetyl 5-methoxytryptamine: an irreversible melatonin ligand?
Chong NW; Evans JE; Sugden D
Biochem Biophys Res Commun; 1993 Jun; 193(3):1355-61. PubMed ID: 8391805
[TBL] [Abstract][Full Text] [Related]
20. The hypnotic and analgesic effects of 2-bromomelatonin.
Naguib M; Baker MT; Spadoni G; Gregerson M
Anesth Analg; 2003 Sep; 97(3):763-768. PubMed ID: 12933398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
